Variation in the vitamin D receptor gene is not associated with risk of colorectal cancer in the Czech Republic

. 2011 Sep ; 42 (3) : 149-54.

Jazyk angličtina Země Spojené státy americké Médium print

Typ dokumentu srovnávací studie, časopisecké články, práce podpořená grantem

Perzistentní odkaz   https://www.medvik.cz/link/pmid20585998

PURPOSE: Increased levels of vitamin D may protect against colorectal cancer (CRC) development and recurrence. Accumulating epidemiologic evidence suggests these effects may be partly mediated by genetic variants of the vitamin D receptor (VDR) proposed to be associated with altered risk of CRC. We wished to determine if common VDR polymorphisms affected CRC risk in the Czech Republic, a homogenous European population with a high CRC incidence rate. METHODS: Frequencies of the common VDR gene polymorphisms rs2238136, rs1544410 (BsmI), rs7975232 (ApaI), and rs731236 (TaqI) were determined using allele-specific PCR in a case control analysis of a series of 754 CRC patients and 627 patients without malignant disease recruited from centers throughout the Czech Republic. Unconditional logistic regression was used to calculate odds ratios and 95% confidence intervals for the association between these variants and risk of CRC. RESULTS: None of the four polymorphisms tested had any significant effect on CRC risk. No significant differences were observed in susceptibility when the population was stratified by anatomical sub-site, sex, BMI, smoking, alcohol, or presence of polyps. CONCLUSIONS: We conclude that common variation in the VDR gene had little effect on its own on predisposition to sporadic CRC in the Czech population.

Zobrazit více v PubMed

Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2485-91 PubMed

Eur J Clin Pharmacol. 2007 Nov;63(11):997-1005 PubMed

Proc Nutr Soc. 2008 May;67(2):115-27 PubMed

Cancer Epidemiol Biomarkers Prev. 2007 Dec;16(12):2752-5 PubMed

J Med Genet. 2005 Mar;42(3):228-34 PubMed

Cancer Epidemiol Biomarkers Prev. 2010 Feb;19(2):525-36 PubMed

Annu Rev Nutr. 2009;29:111-32 PubMed

Am J Physiol Renal Physiol. 2005 Jul;289(1):F8-28 PubMed

Int J Cancer. 2008 Nov 1;123(9):2170-9 PubMed

Crit Rev Eukaryot Gene Expr. 2007;17(1):31-47 PubMed

Anticancer Res. 2009 Sep;29(9):3511-36 PubMed

Am J Epidemiol. 2002 Mar 1;155(5):478-84 PubMed

J Bone Miner Res. 2007 Dec;22 Suppl 2:V81-5 PubMed

Anticancer Res. 2009 Sep;29(9):3699-704 PubMed

Mutat Res. 2008 Feb 1;638(1-2):146-53 PubMed

J Steroid Biochem Mol Biol. 2004 May;89-90(1-5):187-93 PubMed

Gene. 2004 Sep 1;338(2):143-56 PubMed

Carcinogenesis. 2009 Jul;30(7):1170-80 PubMed

Cancer Epidemiol Biomarkers Prev. 2006 Apr;15(4):744-9 PubMed

Ann Epidemiol. 2009 Jul;19(7):468-83 PubMed

Cancer Causes Control. 2004 Nov;15(9):863-72 PubMed

Cancer Epidemiol Biomarkers Prev. 2009 Nov;18(11):2874-81 PubMed

Cancer Epidemiol Biomarkers Prev. 2009 Sep;18(9):2540-8 PubMed

Eur J Cancer Prev. 2009 Nov;18(6):458-75 PubMed

Int J Cancer. 2004 Sep 20;111(5):750-6 PubMed

J Nutr Biochem. 2002 May;13(5):252-264 PubMed

CA Cancer J Clin. 2005 Mar-Apr;55(2):74-108 PubMed

Hum Mol Genet. 2004 Aug 1;13(15):1633-9 PubMed

Hum Mutat. 2009 Apr;30(4):661-8 PubMed

Gastroenterology. 1999 Jun;116(6):1453-6 PubMed

Int J Cancer. 1999 Dec 10;83(6):723-6 PubMed

Najít záznam

Citační ukazatele

Nahrávání dat ...

Možnosti archivace

Nahrávání dat ...